DIN 02543931 — UPLIZNA 10 MG
UPLIZNA is a solution of Inebilizumab marketed by AMGEN CANADA INC. The full Inebilizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02543931
- Brand name
- UPLIZNA
- Active ingredient
- Inebilizumab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- CD19-directed cytolytic antibody (B-cell depleting monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.